Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
14
NCT06689540
Mts105 for Advanced Hepatocellular Carcinoma
Phase: Phase 1
Role: Collaborator
Start: Nov 18, 2024
Completion: Dec 31, 2026